Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2003
03/13/2003CA2457922A1 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003CA2457861A1 Piperidine derivatives useful as ccr5 antagonists
03/13/2003CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
03/13/2003CA2455896A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma
03/13/2003CA2422135A1 Urea derivatives and adhesion molecule inhibitors containing the same as effective ingredients
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289966A1 SUBSTITUTED LACTAMS AS INHIBITORS OF A$g(b) PROTEIN PRODUCTION
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289964A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289963A1 Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289957A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
03/12/2003EP1289956A1 Chemical compounds
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289954A1 Serine protease inhibitors
03/12/2003EP1289953A1 Serine protease inhibitors
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289525A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
03/12/2003EP1289523A1 Use of (di-substituted-phenyl)-pyrimidinyl-imidazole derivatives as jnk-inhibitors
03/12/2003EP1091954B1 Process for producing (8-chloro-3,10-dibromo-6,11-dihydro-5h-benzo 5,6]cyclohepta[1,2-b]pyridin-11-yl)-1-piperidine
03/12/2003EP1012144B1 Method for producing (hetero)aromatic hydroxylamines
03/12/2003EP0874830B1 A metalloproteinase inhibitor, a pharmaceutical composition containing it and the pharmaceutical use and method useful for the preparation thereof
03/12/2003EP0729459B1 Phenyl-alkyl imidazoles as h3-receptor antagonists
03/12/2003EP0672031B1 Catechol diethers as selective pde iv inhibitors
03/12/2003CN1402722A Arylamine derivs. and their use an anti-telomerase
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same
03/12/2003CN1402710A Antipicornaviral compound and compositions, their pharmaceutical uses, and material for their synthesis
03/12/2003CN1402708A Process for production of pyridine derivs.
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1102931C Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action
03/11/2003WO2002022578A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003US6531610 Intermediate acylating carbonate
03/11/2003US6531605 Reacting diazonium salt of aminopyridine or aminobenzene with thionyl chloride in water, electron transfer catalyst; 2-chloropyridine-3-sulfonyl chloride; avoids use of acetic acid and sulfur dioxide; no extraction isolation problems
03/11/2003US6531603 Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone
03/11/2003US6531598 Naphthostyrils
03/11/2003US6531502 3-Methylidenyl-2-indolinone modulators of protein kinase
03/11/2003US6531501 Veterinary parasiticide
03/11/2003US6531494 Gem-substituted αvβ3 antagonists
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531491 Methods of treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation, such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, and psoriasis,
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531474 Inhibitors of caspases
03/11/2003CA2421936A1 (2-azabicyclo[2.2.1]hept-7-yl)methanol derivatives as nicotinic acetylcholine receptor agonists
03/11/2003CA2262837C An asymmetric conjugate addition reaction
03/11/2003CA2254117C 2,4-diaminopyrimidine derivatives
03/11/2003CA2146250C Process for preparing taxane derivatives
03/11/2003CA2121230C 1,3-dihydro-2h-imidazo(4,5-b) quinolin-2-one derivatives
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003018566A1 New piperidinyl derivates as modulators of chemokine receptor activity
03/06/2003WO2003018563A1 Anti-inflammatory and protein kinase inhibitor composition and method of use
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018553A1 Oral antidiabetic agents
03/06/2003WO2003018551A1 New mandelic acid derivatives and their use as thrombin inhibitors
03/06/2003WO2003018538A1 Novel diarylalkene derivatives and novel diarylalkane derivatives
03/06/2003WO2003018021A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/06/2003WO2003018008A1 Apo ai expression accelerating agent
03/06/2003WO2003018004A2 Analgetic pyrroline derivatives
03/06/2003WO2003017764A1 Substituted propargylamines
03/06/2003WO2002099097A8 Novel compounds for chemiluminescense procedures
03/06/2003WO2002083662A3 Azo compounds and process of producing the same and novel intermediate compounds used in the process of producing azo compounds
03/06/2003WO2002072570A3 Non-imidazole compounds as histamine h3 antagonists
03/06/2003WO2002066443A3 2-thioxo-1,2,3,4-tetrahydropyrimidine derivatives
03/06/2003WO2002046160A3 Process for making a thrombin inhibitor
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002004423A8 Thrombin inhibitors comprising an aminoisoquinoline group
03/06/2003WO2002000650A9 Novel compounds possessing antibacterial, antifungal or antitumor activity
03/06/2003US20030045728 Indol-3-yl derivatives
03/06/2003US20030045724 Benzimidazole compound crystal
03/06/2003US20030045723 Useful in treatment of a variety of cytokine related disorders including rheumatoid arthritis, inflammatory bowel disease, septic shock, osteoporosis, osteoarthritis, neuropathic pain, HIV replication, HIV dementia
03/06/2003US20030045565 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/06/2003US20030045554 Such as 1-(2-thien-2'-yl- 2-oxoethyl)-3-((3-phenylmethyl) pyrazol-5-yl)pyridinium bromide for treating diseases caused by the accumulation of AGE (Advanced Glycation Endproducts); antidiabetic/ antiaging agents
03/06/2003US20030045552 Isoindole-imide compounds, compositions, and uses thereof
03/06/2003US20030045549 Cilastazol of mixed crystal structures
03/06/2003US20030045548 Polymorphic forms of 6-[4-(1-cyclohexyl-1H-tetrazol-5-YL)butoxy]-3,4-dihydro-2(1H)-quinolinone
03/06/2003US20030045547 Reacting a 5-hydroxy carbostryil derivative with a tetrazole in the presence of a phase transfer catalyst
03/06/2003US20030045538 Viologen linked acridine based molecule and process for the preparation thereof
03/06/2003US20030045530 Administering a piperazine or piperidine coupled through a linker to a benzhydril
03/06/2003US20030045525 Particularly in the treatment of benign prostatic hyperplasia.
03/06/2003US20030045519 Treating allergy, allergy-induced airway responses, and congestion (e.g., nasal congestion)
03/06/2003US20030045517 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
03/06/2003US20030045516 Chemokine receptor antagonists and methods of use therefor
03/06/2003US20030045515 Cyanoguanidine I kappa B kinase inhibitors as antiproliferative agents for cancer treatment
03/06/2003US20030045479 Novel N-formyl hydroxylamine compounds, compositions and methods of use
03/06/2003US20030045432 Phenyl-substituted cyclic ketoenols
03/06/2003US20030044399 Method of treatment
03/06/2003CA2458621A1 Oral antidiabetic agents
03/06/2003CA2458015A1 Analgetic pyrroline derivatives
03/06/2003CA2457838A1 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1288202A1 N-acyltetrahydroisoquinoline derivatives
03/05/2003EP1286994A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
03/05/2003EP1286992A1 Piperidyindoles as serotonin receptor ligands
1 ... 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 ... 1080